Connect
MJA
MJA

Conundrums in community-acquired pneumonia

Patrick J Bradley
Med J Aust 2007; 186 (2): . || doi: 10.5694/j.1326-5377.2007.tb00823.x
Published online: 15 January 2007

To the Editor: The recent editorial on community-acquired pneumonia (CAP) stated that “even in an era in which penicillin resistance appears to be increasing among some Streptococcus pneumoniae isolates, there have been no documented failures of high-dose penicillin in treating pneumococcal pneumonia or bacteraemia”.1


  • Lakeside Medical Practice, Warilla, NSW.


Correspondence: patbradley@optusnet.com.au

  • 1. Charles PGP, Johnson PDR, Grayson ML. Conundrums in community-acquired pneumonia [editorial]. Med J Aust 2006; 185: 131-132. <MJA full text>
  • 2. Brown RB, Iannini P, Gross P, Kunkel M. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia. Chest 2003; 123: 1503-1511.
  • 3. Waterer GW. Optimal antibiotic treatment in severe pneumococcal pneumonia — time for real answers. Eur J Clin Microbiol Infect Dis 2005; 24: 691-692.
  • 4. Waterer GW, Somes GW, Wunderink RG. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001; 161: 1837-1842.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.